SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 25, 14:54
863.00
-0.10 (-0.01%)
VOLUME 229
AVERAGE VOLUME
5-Day 609
10-Day 1,126
30-Day 2,381
VOLUME SHOCKER
5-Day 609
10-Day 1,126
30-Day 2,381
Prev. Close
863.10
Open Price
868.65
Bid PRICE (QTY.)
860.00 (1)
Offer PRICE (Qty.)
863.00 (62)
Today’s Low/High 855.00 870.00
52 Wk Low/High 796.05 1245.00
LIVE
NSE
May 25, 14:54
857.25
-6.35 (-0.74%)
VOLUME 1,361
AVERAGE VOLUME
5-Day 2,053
10-Day 2,974
30-Day 6,479
VOLUME SHOCKER
5-Day 2,053
10-Day 2,974
30-Day 6,479
Prev. Close
863.60
Open Price
874.50
Bid PRICE (QTY.)
858.05 (1)
Offer PRICE (Qty.)
861.25 (2)
Today’s Low/High 852.00 874.50
52 Wk Low/High 781.00 1243.80
Action in AstraZeneca Pharma

AstraZeneca
Sentimeter

100%
BUY

100% of moneycontrol users recommend buying AstraZeneca. What's your call on AstraZeneca today?
Read Investor view

Standalone
MARKET CAP (Rs Cr)
2,157.50
P/E
-
BOOK VALUE (Rs)
68.64
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
34.10
EPS (TTM)
-
P/C
-
PRICE/BOOK
12.57
DIV YIELD.(%)
-%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
76.01 new
DELIVERY AVERAGES
3-Day 79.94%
5-Day 73.16%
8-Day 59.00%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track AstraZeneca on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 27-May-2015 (Audited Results)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

22 May 2015

buy

AdaniPorts May Fut

Entry Price (Rs)

350.00

Exit Price (Rs)

354.50

Gain (Rs)

5.00

buy

SunPharma May Fut

Entry Price (Rs)

983.00

Exit Price (Rs)

991.00

Gain (Rs)

8.00

buy

Larsen May Fut

Entry Price (Rs)

1,638.00

Exit Price (Rs)

1,653.75

Gain (Rs)

16.00

buy

CADILA HEALT May Fut

Entry Price (Rs)

1,755.00

Exit Price (Rs)

1,794.00

Gain (Rs)

39.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 1134.65 868.65  
High Price 1140.00 870.00  
Low Price 1110.00 855.00  
Last Price 1123.00 863.00 -23.15
Volume 2,215 229 -89.66
Simple Moving Averages
Days BSE NSE
30 904.65 904.95
50 914.54 914.58
150 873.83 874.01
200 904.35 904.39

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for AstraZeneca

The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
Pre Opening Session Prices 9:00 - 9:15
BSE - No shares traded
NSE
May 25, 09:07
874.50
10.90 (+1.26%)
High
899.00
Low
874.50
News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Dec'14 Sep'14 Jun'14
Mar'14
Net Sales 108.12 114.55 125.57 114.15
Other Income 1.10 1.61 1.79 1.42
PBDIT -10.14 -26.11 -15.96 -14.90
Net Profit -13.41 -27.96 -17.60 -2.57

Annual Report

Download in PDF format 2014 |2013 |2012 |2011
Balance Sheet
Mar'14
(In Rs Cr)
Total Share Capital 5.00
Net Worth 171.60
Total Debt 0.00
Net Block 94.22
Investments 0.00
Total Assets 171.60
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 1000.90 -0.24 1200.70 586.90 240,858.91
Lupin 1770.05 1.98 2112.00 928.80 79,623.02
Dr Reddys Labs 3594.00 -1.24 3808.75 2332.50 61,234.99
Cipla 663.00 -1.64 752.45 385.00 53,236.28
Aurobindo Pharm 1353.00 -0.66 1432.10 628.10 39,505.20
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 15Dec' 14Sep' 14Jun' 14
Promoter75.0075.0075.0075.00
FII15.6815.6615.6615.96
DII0.010.030.270.32
Others9.319.319.078.72
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Block N1, 12th Floor,,Manyata Embassy Business Park,
City
Bangalore
State
Karnataka
Pin Code
560045
Tel. No.
080-23622020-22 080-67748000
Fax No.
080-23622015
REGISTRARS
Name
Integrated Enterprises (India) Ltd.
Address
No.30, Ramana Residency 4th Cross, Sampige Road Malleswaram
City
Bangalore - 560003
State
Karnataka
Tel. No.
080-23460815
Fax No.
080-23460819
Email:
Internet
MANAGEMENT
Name
Designation
D E Udwadia
Chairman
Sanjay Murdeshwar
Managing Director
Robert Ian Haxton
Whole Time Director
Ian Brimicombe
Director
K S Shah
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Allcargo Logistics Recommended on Apr 27th 2015

Recommended price 316.00  |  Peak from reco 353.00 11.87%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About AstraZeneca

AstraZeneca is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,157.50 crore.

The company management includes D E Udwadia - Chairman, Sanjay Murdeshwar - Managing Director, Robert Ian Haxton - Whole Time Director, Ian Brimicombe - Director, K S Shah - Director, Narayan K Seshadri - Director, Justin Ooi - Director, Rebekah Martin - Additional Director.

It is listed on the BSE with a BSE Code of 506820 and the NSE with an NSE Code of ASTRAZEN.

Its Registered office is at Block N1, 12th Floor,,Manyata Embassy Business Park, Bangalore,Karnataka - 560045.

Their Registrars are Integrated Enterprises (India) Ltd.

Quick Links for AstraZeneca Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of AstraZeneca